Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypoxia-Ischemia, Brain | 8 | 2019 | 56 | 3.470 |
Why?
|
| Hypothermia, Induced | 7 | 2018 | 93 | 2.920 |
Why?
|
| Acetylcysteine | 8 | 2020 | 296 | 2.800 |
Why?
|
| Neuroprotective Agents | 4 | 2017 | 317 | 1.300 |
Why?
|
| Infant, Premature | 2 | 2015 | 284 | 0.850 |
Why?
|
| Motor Skills | 3 | 2017 | 88 | 0.740 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 2020 | 27 | 0.710 |
Why?
|
| Glutathione | 2 | 2020 | 343 | 0.710 |
Why?
|
| Vagus Nerve Stimulation | 4 | 2022 | 61 | 0.680 |
Why?
|
| Chorioamnionitis | 2 | 2015 | 40 | 0.620 |
Why?
|
| Child Development | 2 | 2015 | 102 | 0.600 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2018 | 91 | 0.600 |
Why?
|
| Oxidative Stress | 2 | 2020 | 718 | 0.600 |
Why?
|
| Antioxidants | 2 | 2017 | 304 | 0.600 |
Why?
|
| Infant, Newborn | 9 | 2020 | 2453 | 0.590 |
Why?
|
| Calcitriol | 1 | 2017 | 106 | 0.590 |
Why?
|
| Animals, Newborn | 5 | 2020 | 396 | 0.580 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 498 | 0.490 |
Why?
|
| Motor Skills Disorders | 1 | 2014 | 7 | 0.490 |
Why?
|
| Vitamin D Deficiency | 1 | 2017 | 292 | 0.480 |
Why?
|
| Movement | 1 | 2015 | 179 | 0.470 |
Why?
|
| Placenta | 1 | 2014 | 101 | 0.470 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2020 | 346 | 0.460 |
Why?
|
| Leukocytes | 1 | 2013 | 99 | 0.460 |
Why?
|
| Chemokines | 1 | 2013 | 119 | 0.450 |
Why?
|
| Brain Injuries | 2 | 2021 | 268 | 0.430 |
Why?
|
| Time Factors | 7 | 2019 | 4655 | 0.420 |
Why?
|
| Cytokines | 2 | 2017 | 866 | 0.420 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 3 | 2022 | 40 | 0.400 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2020 | 2083 | 0.380 |
Why?
|
| Infant | 6 | 2019 | 2891 | 0.360 |
Why?
|
| Female | 14 | 2020 | 38015 | 0.330 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2009 | 154 | 0.320 |
Why?
|
| Male | 12 | 2019 | 37281 | 0.290 |
Why?
|
| Pregnancy | 4 | 2020 | 2331 | 0.280 |
Why?
|
| Stroke | 1 | 2018 | 2161 | 0.260 |
Why?
|
| Vitamin D | 2 | 2017 | 516 | 0.220 |
Why?
|
| Humans | 15 | 2022 | 68525 | 0.200 |
Why?
|
| Prospective Studies | 4 | 2022 | 3702 | 0.190 |
Why?
|
| Sex Factors | 2 | 2016 | 1265 | 0.190 |
Why?
|
| Neurological Rehabilitation | 1 | 2020 | 12 | 0.180 |
Why?
|
| Animals | 5 | 2020 | 20877 | 0.180 |
Why?
|
| Pregnancy, Animal | 1 | 2020 | 27 | 0.180 |
Why?
|
| Osmosis | 1 | 2020 | 38 | 0.180 |
Why?
|
| Feeding and Eating Disorders | 1 | 2022 | 106 | 0.180 |
Why?
|
| Naloxone | 1 | 2020 | 56 | 0.180 |
Why?
|
| Vagus Nerve | 4 | 2022 | 90 | 0.180 |
Why?
|
| Maternal Exposure | 1 | 2020 | 75 | 0.170 |
Why?
|
| Cohort Studies | 2 | 2017 | 2356 | 0.170 |
Why?
|
| Central Nervous System | 1 | 2020 | 107 | 0.170 |
Why?
|
| Inflammation | 2 | 2017 | 1030 | 0.170 |
Why?
|
| Transcranial Direct Current Stimulation | 1 | 2021 | 111 | 0.170 |
Why?
|
| Laboratories | 1 | 2019 | 44 | 0.170 |
Why?
|
| Treatment Outcome | 3 | 2017 | 7028 | 0.160 |
Why?
|
| Vitamin D3 24-Hydroxylase | 1 | 2017 | 24 | 0.150 |
Why?
|
| Pediatrics | 1 | 2021 | 341 | 0.150 |
Why?
|
| Phosphorus | 1 | 2017 | 64 | 0.150 |
Why?
|
| Maze Learning | 1 | 2017 | 138 | 0.150 |
Why?
|
| Behavior, Animal | 1 | 2020 | 470 | 0.150 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2017 | 58 | 0.140 |
Why?
|
| Glutamic Acid | 1 | 2020 | 332 | 0.140 |
Why?
|
| Motor Activity | 1 | 2020 | 621 | 0.140 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 567 | 0.140 |
Why?
|
| Mothers | 2 | 2015 | 172 | 0.140 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 2550 | 0.140 |
Why?
|
| Rats | 2 | 2020 | 5300 | 0.140 |
Why?
|
| Brain | 3 | 2021 | 2175 | 0.140 |
Why?
|
| Random Allocation | 1 | 2017 | 442 | 0.140 |
Why?
|
| Th17 Cells | 1 | 2017 | 116 | 0.140 |
Why?
|
| Brain Infarction | 1 | 2016 | 54 | 0.130 |
Why?
|
| Memory | 1 | 2017 | 214 | 0.130 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2016 | 201 | 0.130 |
Why?
|
| Caspase 3 | 1 | 2016 | 233 | 0.130 |
Why?
|
| Sex Characteristics | 1 | 2017 | 295 | 0.130 |
Why?
|
| Cell Death | 1 | 2016 | 329 | 0.130 |
Why?
|
| Head | 1 | 2015 | 59 | 0.130 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2014 | 57 | 0.120 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 244 | 0.120 |
Why?
|
| Fetal Blood | 1 | 2014 | 131 | 0.120 |
Why?
|
| Enzyme Activation | 1 | 2016 | 791 | 0.120 |
Why?
|
| Infusions, Intravenous | 1 | 2014 | 334 | 0.120 |
Why?
|
| Hippocampus | 1 | 2017 | 471 | 0.120 |
Why?
|
| Free Radical Scavengers | 1 | 2014 | 112 | 0.120 |
Why?
|
| Double-Blind Method | 2 | 2015 | 1737 | 0.120 |
Why?
|
| Leukocyte Count | 1 | 2013 | 94 | 0.120 |
Why?
|
| Biomechanical Phenomena | 1 | 2015 | 368 | 0.120 |
Why?
|
| Psychomotor Performance | 1 | 2015 | 213 | 0.110 |
Why?
|
| Developmental Disabilities | 1 | 2014 | 119 | 0.110 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2013 | 113 | 0.110 |
Why?
|
| Chemokine CCL3 | 1 | 2012 | 9 | 0.110 |
Why?
|
| Interleukin-12 | 1 | 2012 | 75 | 0.110 |
Why?
|
| Chemokine CCL2 | 1 | 2012 | 101 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 1745 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2018 | 2222 | 0.100 |
Why?
|
| Neuropsychological Tests | 1 | 2014 | 517 | 0.100 |
Why?
|
| Interleukin-6 | 1 | 2012 | 330 | 0.100 |
Why?
|
| Pilot Projects | 1 | 2014 | 1341 | 0.090 |
Why?
|
| Myelin Sheath | 1 | 2009 | 115 | 0.090 |
Why?
|
| Oligodendroglia | 1 | 2009 | 107 | 0.080 |
Why?
|
| Polysaccharides | 1 | 2009 | 176 | 0.080 |
Why?
|
| Prognosis | 1 | 2012 | 2093 | 0.070 |
Why?
|
| Risk Factors | 1 | 2017 | 5719 | 0.070 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2006 | 20 | 0.070 |
Why?
|
| Myelin Basic Protein | 1 | 2006 | 62 | 0.070 |
Why?
|
| Adult | 3 | 2021 | 21375 | 0.070 |
Why?
|
| Research Design | 1 | 2009 | 729 | 0.060 |
Why?
|
| Combined Modality Therapy | 1 | 2006 | 951 | 0.060 |
Why?
|
| Electromyography | 1 | 2020 | 184 | 0.040 |
Why?
|
| Metabolome | 1 | 2019 | 15 | 0.040 |
Why?
|
| Basal Ganglia | 1 | 2019 | 45 | 0.040 |
Why?
|
| Electricity | 1 | 2019 | 33 | 0.040 |
Why?
|
| Perception | 1 | 2019 | 189 | 0.040 |
Why?
|
| Electric Stimulation | 1 | 2018 | 218 | 0.040 |
Why?
|
| User-Computer Interface | 1 | 2019 | 230 | 0.040 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2021 | 413 | 0.040 |
Why?
|
| Echoencephalography | 1 | 2015 | 10 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 2015 | 57 | 0.030 |
Why?
|
| Stroke Rehabilitation | 1 | 2020 | 334 | 0.030 |
Why?
|
| Fetus | 1 | 2015 | 157 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 2077 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 1 | 2015 | 296 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2015 | 418 | 0.030 |
Why?
|
| Child | 1 | 2021 | 6400 | 0.020 |
Why?
|